Company Short-Term Debts: Predictive Oncology Inc (POAI)

Predictive Oncology Corp (POAI) - corporate logo

Predictive Oncology is pursuing the expansion of B2B subscriptions for its AI drug analysis software. The history of short-term credits and loans demonstrates the dynamics of this process, where 0.00 reflects the latest metric value. Success is constrained by algorithmic accuracy and access to biobanks, as well as a dependence on the R&D budgets of pharma behemoths, which necessitates strict cost control.

POAI (Predictive Oncology) Company Short-Term Debts history from 07/04/2022 to 12/12/2025

Summary analytical data breakdowns for Predictive Oncology Inc (POAI)

- price and consensus price forecast:
Stock Price Predictive Oncology Corp|POAI - Analyst Median Target
- market capitalization data:
Market Capitalization Predictive Oncology Inc.|POAI - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Predictive Oncology|POAI - Book Capitalization|Market Value to Book Value Ratio predictive-oncology.com|POAI - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Predictive Oncology|POAI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Predictive Oncology Corp|POAI - Company Total Debt Obligations|Debt to Book Capitalization Ratio Predictive Oncology Inc.|POAI - Company Long-Term Indebtedness|Company Short-Term Debt Predictive Oncology
Fundamental company valuation:Predictive Oncology
Signature product of Predictive Oncology Inc

Predictive Oncology is scaling its AI platform for tumor modeling, offering pharmaceutical behemoths software solutions to optimize preclinical trials. By analyzing the size of short-term debt, an investor assesses obligations maturing within one year, which allows for the determination of the risk of a liquidity gap or, conversely, the management's conservatism regarding the aggressive financing of business expansion.

Competitor analysis for Predictive Oncology

Company Short-Term Debts ISRG (Intuitive)|DHR - Short-Term Debt Volume|BDX (Becton, Dickinson and Company) - Company Short-Term Debts|STERIS Group (STE) - Company Current Liabilities|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts BAX|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt Stevanato Group SpA STVN|Company Current Liabilities Teleflex Inc|Company Short-Term Loans and Borrowings Merit Medical Corp MMSI|Company Short-Term Debts NVST (Envista Holdings)|ICUI: Short-Term Debt Volume|Company Short-Term Debt Dentsply Sirona|LMAT (LeMaitre Vascular Inc) - Company Short-Term Indebtedness|ATRC: Company Short-Term Debt|Short-Term Debt Volume STAAR Surgical Co (STAA)|Company Current Liabilities ChromaDex|Amount of Current Liabilities ZIMV (zimvie.com)|Company Short-Term Debt AngioDynamics|CERS - Company Short-Term Loans and Borrowings|Alpha Teknova Inc - Company Current Liabilities|MGRM: Company Short-Term Debts|STSS (sharpstechnology.com) - Company Short-Term Debt|InfuSystem Holdings, Inc. (INFU) - Company Current Liabilities|Company Short-Term Debts UTMD (Utah Medical Products, Inc.)|Short-Term Debt KRMD|Company Short-Term Debt Nyxoah, S.A. NYXH|Company Short-Term Indebtedness Microbot Medical, Inc MBOT|Company Current Liabilities Pro-Dex, Inc. (PDEX)|zentek.com - Amount of Current Liabilities|Company Short-Term Debt ELUT (Elutia)|MLSS: Short-Term Debt Volume|Company Short-Term Debt NEXGEL, Inc (NXGL)|RVP (Retractable Technologies, Inc.) - Current Liabilities|HBIO - Company Short-Term Debt|Company Short-Term Loans and Borrowings femasys.com|MeihuaMed - Company Short-Term Debts|Short-Term Debt callanjmb.com (CJMB)|ATRI - Company Short-Term Debts|Company Short-Term Indebtedness NeuroMetrix Corporation NURO